Humanigen Announces Peer-Reviewed Publication in The Journal of Medical Economics Demonstrating the Clinical and Economic Benefits of Lenzilumab
Lenzilumab plus standard of care (SOC), resulted in an estimated cost…
Lenzilumab plus standard of care (SOC), resulted in an estimated cost…
Sign in to your account